The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Effect of Captopril on Heavy Proteinuria in Azotemic Diabetics
Taguma, Y., Kitamoto, Y., Futaki, G., Ueda, H., Monma, H., Ishizaki, M., Takahashi, H., Sekino, H., & Sasaki, Y. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512263132601 · Cited by 412
Bjorck, S., Nyberg, G., Mulec, H., Granerus, G., Herlitz, H., & Aurell, M. (1986) · BMJ · doi:10.1136/bmj.293.6545.471 · Cited by 405
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
Hommel, E., Parving, H. H., Mathiesen, E., Edsberg, B., Damkjaer Nielsen, M., & Giese, J. (1986) · BMJ · doi:10.1136/bmj.293.6545.467 · Cited by 308
Reversing glomerular hypertension stabilizes established glomerular injury
Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1987) · Kidney International · doi:10.1038/ki.1987.62 · Cited by 268
The Effect of Indomethacin on Kidney Function and Plasma Renin Activity in Man
Donker, A. J. M., Arisz, L., Brentjens, J. R. H., van der Hem, G. K., & Hollemans, H. J. G. (1976) · Nephron · doi:10.1159/000180733 · Cited by 257
Self-citationThe Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic Syndrome
Arisz, L., Donker, A. J. M., Brentjens, J. R. H., & van der Hem, G. K. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb06701.x · Cited by 171
Williams, P. S., Fass, G., & Bone, J. M. (1988) · QJM · doi:10.1093/oxfordjournals.qjmed.a068203 · Cited by 146
Treatment of the Nephrotic Syndrome with Indomethacin
Donker, A. J. M., Brentjens, J. R., van der Hem, G. K., & Arisz, L. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000181478 · Cited by 83
Cited by
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
He, F. J., & MacGregor, G. A. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.144 · Cited by 1,123
Understanding the nature of renal disease progression
Remuzzi, G., Ruggenenti, P., & Benigni, A. (1997) · Kidney International · doi:10.1038/ki.1997.2 · Cited by 649
Reducing population salt intake worldwide: from evidence to implementation
He, F. J., & MacGregor, G. A. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.006 · Cited by 625
Salt Reduction to Prevent Hypertension and Cardiovascular Disease
He, F. J., Tan, M., Ma, Y., & MacGregor, G. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.055 · Cited by 589
Keane, W. F., & Eknoyan, G. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70442-7 · Cited by 591
Orth, S. R., & Ritz, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381707 · Cited by 533
Obesity, hypertension, and chronic kidney disease
Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520
Renal protective effect of enalapril in diabetic nephropathy.
Bjorck, S., Mulec, H., Johnsen, S. A., Norden, G., & Aurell, M. (1992) · BMJ · doi:10.1136/bmj.304.6823.339 · Cited by 432
Guidelines for the management of chronic kidney disease
Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Burns, K., Manns, B., White, C., Madore, F., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080351 · Cited by 420
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease
Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., Marcantoni, C., De Jong, P. E., De Zeeuw, D., Shahinfar, S., Ruggenenti, P., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031131.x · Cited by 377
Self-citationEffects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
Vogt, L., Waanders, F., Boomsma, F., de Zeeuw, D., & Navis, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060693 · Cited by 372
Self-citationMicroalbuminuria and Cardiovascular Disease
Weir, M. R. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03190906 · Cited by 342
Slagman, M. C. J., Waanders, F., Hemmelder, M. H., Woittiez, A.-J., Janssen, W. M. T., Lambers Heerspink, H. J., Navis, G., Laverman, G. D., & for the HONEST (HOlland NEphrology STudy) Group (2011) · BMJ · doi:10.1136/bmj.d4366 · Cited by 286
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
Bakris, G. L., Weir, M. R., Dequattro, V., & McMahon, F. G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00083.x · Cited by 276
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
Remuzzi, G., Ruggenenti, P., & Perico, N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00010 · Cited by 272
Salt and hypertension: is salt dietary reduction worth the effort?
Frisoli, T. M., Schmieder, R. E., Grodzicki, T., & Messerli, F. H. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.023 · Cited by 200
The double challenge of resistant hypertension and chronic kidney disease
Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00418-3 · Cited by 194
Medications that cause weight gain and alternatives in Canada: a narrative review
Wharton, S., Raiber, L., Serodio, K., Lee, J., & Christensen, R. A. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s171365 · Cited by 100
Metadata
- Authors
- Heeg, J. E., de Jong, P. E., van der Hem, G. K., & de Zeeuw, D.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 1989-08
- Volume
- 36
- Issue
- 2
- Pages
- 272-279
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2075577088
- Cited by
- 363
- References
- 15
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.